Ashland Inc (ASH)
79.05
+1.41
(+1.82%)
USD |
NYSE |
Nov 22, 16:00
77.01
-2.04
(-2.58%)
Pre-Market: 05:05
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 3.724B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 3.04% |
| Valuation | |
| PE Ratio | 23.60 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 1.870 |
| Price to Book Value | 1.298 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.405 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.4704 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 52.83% |
Profile
| Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. The company generates its sales from North America, Europe, Asia Pacific, and Latin America, and Others. |
| URL | http://www.ashland.com |
| Investor Relations URL | https://investor.ashland.com/ |
| HQ State/Province | Delaware |
| Sector | Materials |
| Industry | Chemicals |
| Equity Style | Small Cap/Blend |
| Next Earnings Release | Jan. 30, 2025 (est.) |
| Last Earnings Release | Nov. 06, 2024 |
| Next Ex-Dividend Date | Nov. 29, 2024 |
| Last Ex-Dividend Date | Aug. 30, 2024 |
Ratings
Profile
| Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. The company generates its sales from North America, Europe, Asia Pacific, and Latin America, and Others. |
| URL | http://www.ashland.com |
| Investor Relations URL | https://investor.ashland.com/ |
| HQ State/Province | Delaware |
| Sector | Materials |
| Industry | Chemicals |
| Equity Style | Small Cap/Blend |
| Next Earnings Release | Jan. 30, 2025 (est.) |
| Last Earnings Release | Nov. 06, 2024 |
| Next Ex-Dividend Date | Nov. 29, 2024 |
| Last Ex-Dividend Date | Aug. 30, 2024 |